Compare ANNX & LXU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANNX | LXU |
|---|---|---|
| Founded | 2011 | 1968 |
| Country | United States | United States |
| Employees | N/A | 513 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 972.5M | 1.0B |
| IPO Year | 2020 | 2006 |
| Metric | ANNX | LXU |
|---|---|---|
| Price | $5.40 | $14.38 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 4 |
| Target Price | ★ $16.50 | $14.63 |
| AVG Volume (30 Days) | ★ 2.0M | 1.2M |
| Earning Date | 05-11-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 225.93 |
| EPS | N/A | ★ 0.27 |
| Revenue | N/A | ★ $615,208,000.00 |
| Revenue This Year | N/A | $13.69 |
| Revenue Next Year | $16,320.74 | N/A |
| P/E Ratio | ★ N/A | $54.72 |
| Revenue Growth | N/A | ★ 17.77 |
| 52 Week Low | $1.85 | $6.80 |
| 52 Week High | $7.18 | $17.22 |
| Indicator | ANNX | LXU |
|---|---|---|
| Relative Strength Index (RSI) | 39.87 | 49.04 |
| Support Level | $4.79 | $13.24 |
| Resistance Level | $5.61 | $15.59 |
| Average True Range (ATR) | 0.28 | 0.78 |
| MACD | -0.07 | -0.02 |
| Stochastic Oscillator | 12.76 | 41.73 |
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.
LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.